Several mortality prediction scores are available for patients with upper gastrointestinal bleeding who visited the emergency department; however, most of the available scores include endoscopic data. Endoscopy is difficult or impossible to access for many emergencies departments worldwide. The aim of this study was to evaluate and compare the performance of the albumin, INR, alteration in mental status, systolic blood pressure and age 65 score and the Glasgow-Blatchford score in predicting mortality in patients with upper gastrointestinal bleeding who visited the emergency department and for which endoscopic data were not required. The data of patients with acute upper gastrointestinal bleeding who visited the emergency department during the study period were retrospectively analyzed. The data were obtained from the hospital automation system using the international classification of disease codes via computer registration. The prediction accuracy of AIMS65 and Glasgow-Blatchford score was compared using the area under the receiver operating characteristic curve method. There were 422 patients in total; the mean age of these patients was 68.5 while 62.6% were males. The mortality rate was 30 (7.1%). The AIMS65 score performed better with an AUC 0.706 [95%CI 0.660-0.749; p<0.001] compared with the Glasgow-Blatchford score (AUC 0.542; 95%CI 0.4693-0.576; p=0.11). In this study, it was revealed that AIMS65, which is a score that can be easily calculated only with the data in the emergency department, outperformed Glasgow-Blatchford score in predicting mortality in patients with acute upper gastrointestinal bleeding who visited the emergency department.
3 April 2021 in International Journal Of Clinical Practice
Objective This study assessed whether lactate clearance (LC) during the first 2 hours after admission to the emergency department can be used to predict the 30‐day mortality of patients diagnosed with diabetic ketoacidosis (DKA). Material and Methods This was a retrospective observational cohort study of patients admitted to hospital between January 2014 and January 2019. We identified patients with diabetes who had blood gas test results at the time of admission and 2 hours thereafter. We then calculated the LC in these patients. Patients were divided into groups based on mortality and length of stay (LOS). The groups were compared in terms of age, blood gas pH, osmolarity, glucose level, lactate level on admission and 2 hours thereafter, LC, and bicarbonate (HCO3−), blood urea nitrogen, sodium, and potassium levels. Results The overall mortality rate was 7.54% (8/107). Age, pH, osmolarity, the HCO3−and sodium levels, the lactate level 2 hours after admission, and LC differed significantly between the groups (Mann–Whitney U test, p<0.05). LC cut‐off values and areas under the curve were significant (p<0.05). Receiver operating characteristic analysis indicated an LC cut‐off value of 18.6441; the area under the curve was 0.711 (p<0.05). Conclusions LC during the first 2 hours after admission is useful for predicting 30‐day mortality in patients with diabetic ketoacidosis.
15 November 2022 in The American Journal of Emergency Medicine
Objective: Our aim in this study to determine the relationship between the blood gas lactate values of the patients who have 2019 coronavirus disease (COVID-19) at the time of admission to the emergency department (ED) and the mortality status of these patients and the intensive care unit (ICU) requirement. Methods: This retrospective observational study was conducted with patients who were diagnosed with COVID-19 in the emergency department of a tertiary hospital. The study was continued with the remaining 292 patients after using the inclusion and exclusion criteria. Patients included in the study were divided into 2 groups according to their lactate levels (Lactate ≤ 2 mmol/L and Lactate > 2 mmol/L). Then we compared the groups according to their ICU requirement and mortality status. Results: There were 292 patients included in this study. The mean age of the patients was 68.3 ± 15.9, of which 158 were men and 134 were women. Hyperlactatemia (lactate >2) was found in 136 (46.6%) of the 292 patients included in the study, while 156 (53.4%) had normal lactate levels (lactate ≤2). The most common comorbidities in the patients were hypertension (HT), diabetes mellitus (DM), and cardiovascular diseases. ICU requirements and mortality status of the patients in the study, when compared with lactate levels, the mortality and ICU rates of the hyperlactatemia group were statistically higher. Conclusion: Our study found that hyperlactatemic COVID-19 patients had higher ICU requirement and mortality rates compared to non-hyperlactatemic patients. Prospective studies with larger sample sizes are necessary to adequately assess the relationship between lactate and mortality in COVID-19 patients.